Pharmacotherapy of generalized anxiety disorder

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 11, 2001, Pages 46-52

  Davidson, J R T ^a   Ballenger, J C ^a   Lecrubier, Y ^a   Rickels, K ^a   Borkovec, T D ^a   Stein, D J ^a   Nutt, D J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; DELORAZEPAM; DIAZEPAM; HYDROXYZINE; IMIPRAMINE; PAROXETINE; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VENLAFAXINE;

ANXIETY NEUROSIS; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; CONSTIPATION; DEPRESSION; DISABILITY; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; HEART RATE VARIABILITY; HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; WITHDRAWAL SYNDROME; XEROSTOMIA;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; BENZODIAZEPINES; BUSPIRONE; COMORBIDITY; DEPRESSIVE DISORDER; HEART RATE; HUMANS; HYDROXYZINE; SEROTONIN AGONISTS; TREATMENT OUTCOME;

EID: 0034970413     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Generalized anxiety disorder: Nature and course
2. Antidepressants, anxiety, panic and phobia
3. Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms
4. Imipramine dose-response relationship in panic disorder with agoraphobia: Preliminary findings
5. Treatment of posttraumatic stress disorder with amitriptyline and placebo
6. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine
7. Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone and diazepam
8. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder
9. Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder
10. Long-term diazepam therapy and clinical outcome
11. Use of benzodiazepines in anxiety disorders
12. The spectrum of generalized anxiety in clinical practice: The role of short-term, intermittent treatment
13. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder
14. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder
15. Benzodiazepines in general practice time for decision
16. Buspirone: Chemical profile of a new class of anxioselective agents
17. Neuropharmacology of buspirone
18. Buspirone, a new approach to the treatment of anxiety
19. Buspirone and diazepam in anxiety: A controlled study
20. Treatment of generalized anxiety disorder: Preliminary clinical experience with buspirone
21. A double-blind, controlled trial in primary care patients with generalized anxiety: A comparison between buspirone and oxazepam
22. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder
23. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients
24. Comparison of withdrawal of buspirone and diazepam: A placebo controlled study
25. A comparison of buspirone, diazepam and placebo in patients with chronic anxiety states
26. Controlled comparison of buspirone and oxazepam in generalized anxiety
27. Neurotic illness and its response to anxiolytic and antidepressant treatment
28. Imipramine and chlordiazepoxide in depressive and anxiety disorders, 2: Efficacy in anxious outpatients
29. Differential effects of alprazolam and imipramine in generalized anxiety disorder: Somatic versus psychic symptoms
30. Overview of antidepressants currently used to treat anxiety disorders
31. The Hopkins Symptom Checklist (HSCL): Factors derived from the HSCL-90
32. The psychological profile of the transsexual
33. Characteristics of chronic anxiety patients
34. Hamilton rating scale for anxiety
35. Recent developments in the psychopharmacology of anxiety disorders
36. Pharmacotherapy of social anxiety disorder
37. Sertraline in the treatment of obsessive compulsive disorder: Two double-blind, placebo-controlled studies
38. The effect of paroxetine on anxiety and agitation associated with depression
39. Paroxetine efficacy in the treatment of generalized anxiety disorder
40. Short-term efficacy of paroxetine in generalized anxiety disorder: A double-blind placebo controlled trial
41. Paroxetine is effective in the treatment of generalized anxiety disorder: Results from a randomized placebo-controlled flexible dose study
42. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients
43. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder
44. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial
45. The hospital anxiety and depression scale
46. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder
47. A multicentre, double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder
48. Autonomic characteristics of generalized anxiety disorder and worry
49. Paroxetine increases heart rate variability in panic disorder
50. Effect of imipramine on heart rate variability measures